Sentences with phrase «of pharmacogenetics»

He has published over 175 articles in this field of pharmacogenetics.

He is head of the Pharmacogenetics Core Laboratory AKC (part of BO&O) and he is responsible for Point - of - Care testing at the Erasmus MC.

Ron H.N. van Schaik, PhD is a registered European Clinical Chemist (2003) andProfessor of Pharmacogenetics (2008).

Prof. Dr. Ron van Schaik, PhD is a registered European specialist Laboratory medicine (2003) and a Full Professor of Pharmacogenetics (2013).

The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical pharmacogenomics.

Her primary interests are in treatment and pharmacogenetics of childhood leukemia and clinical implementation of pharmacogenetic testing.

Similarly an accusation of deliberate murder by poisoning by a care home was revealed to have been likely to have naturally arisen as a result of a pharmacogenetic cause resulting in the victim being unable to excrete the prescribed tranquiliser in question.

Not exact matches

The study of drug interactions and ultimately pharmacogenetics then took off.

Using a pharmacogenetics approach, the researchers selectively switched off specific groups of brain cells — called neural ensembles — that react to select cues signaling either reward availability or reward omission.

Amàlia Lafuente is a professor of pharmacology specializing in pharmacogenetics and vice chair of the Department of Pathological Anatomy, Pharmacology, and Microbiology in the School of Medicine at the University of Barcelona in Spain.

He also actively participates in several major international consortium, such as International Warfarin Pharmacogenetic Consortium, International Clopidogrel Pharmacogenetic Consortium, Clinical Pharmacogenetics Implementation Consortium and worked with a group of experts to develop clinical use of HLA - B * 5801 and allopurinol.

«With the inauguration of the Institute for Personalized Medicine, we have reasserted our early leadership in the science of tailoring therapy to individuals, an approach that in some ways began at Hershey with the observations around pharmacogenetics by our founding chair of pharmacology, Elliot Vesell, more than 40 years ago,» said Daniel Notterman, vice dean for research and graduate studies.

We worked with Brian Gage and Deepak Voora on the pharmacogenetics of warfarin (coumadin), a widely - used oral anticoagulant.

The lovely violin plots at right show the mean GERP scores (a measure of conservation) for included versus excluded variants in the newborn screening (NBS), age - related macular degeneration (ARMD), and pharmacogenetics (PGx) genes examined.

His major achievement is in the pharmacogenetic study of warfarin dose requirements, which resulted in the identification the SNP associated with warfarin dose.

He is Director of the International (IFCC) Reference Center for Pharmacogenetics and he leads the Unit Research & Development of the Dept. Clinical Chemistry.

Professor; Pharmacogenetics group, Department of Physiology and Pharmacology, Karolinska Universitet, Stockholm, Sweden

• Pharmacogenetics The unit offers population screening for a number of validated polymorphisms with pharmacogenetic implications, associated with positive or negative responses to therapeutic agents.

Since her initial published findings in a 2001 issue of the journal Pharmacogenetics, Mealey discovered 12 other dog breeds, including Long - Haired Whippets and Silken Windhounds, are susceptible.

He has been at the forefront of developing and applying new technologies for neural circuit manipulation, such as optogenetics and pharmacogenetics, to the study of emotional behaviors such as fear, anxiety and aggression, in both mice and fruit flies.

We also perform pharmacogenetics testing to help physicians choose the right drug at the right time for treatment of childhood epilepsy and other disorders.

The National Institutes of Health funded the study through a grant to the Pharmacogenetics of Anticancer Agents Research Group.

One of Dr. Innocentis exemplary achievements is the elucidation of the genetic basis of severe neutropenia in cancer patients treated with irinotecan, a poster child for pharmacogenetic.

Dr. Innocenti sits on the editorial board of Journal of Clinical Oncology, Pharmacogenetics and Genomics, Therapeutic Drug Monitoring, Current Drug Metabolism, and others.

He joined UNC in January 2011 after twelve years of research in cancer pharmacogenetics at the University of Chicago.

Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA - 824 with concomitant lopinavir - ritonavir, efavirenz, or rifampin.

Pharmacogenetics is the study of how different groups of people respond to drugs, based on their genetic makeup.

- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing; Stephen Kimmel, MD, MSCE, Perelman School of Medicine at the University of Pennsylvania.

Molecular actions and clinical pharmacogenetics of lithium therapy.

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learning activities.

A pharmacogenetic «restriction - of - function» approach reveals evidence for anxiolytic - like actions mediated by α5 - containing GABAA receptors in mice.

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing; Stephen Kimmel, MD, MSCE, Perelman School of Medicine at the University of Pennsylvania.

This session will explore some common drugs and the genetics of their metabolism; will also overview pharmacogenetic nomenclature, and lastly, will review guidelines that support pharmacogenetic testing.

Understanding individual variability in the effects of antipsychotic drugs - Pharmacogenetics to epigenetics

3 - 4 pm: Stephen Miller (Poster presentation)- The I - PICC Study: Protocol for a point - of - care randomized controlled trial of statin pharmacogenetics in a learning healthcare system

Dr. Relling is part of NIH's Pharmacogenomics Research Network and co-founder of CPIC, the Clinical Pharmacogenetics Implementation Consortium.

He is a member of the Scientific Advisory Board of the Clinical Pharmacogenetic Implementation Consortium (CPIC) and a member of the CPIC informatics committee and has participated in guideline creation and review for that group.

Residents of nursing homes that performed pharmacogenetic testing had reductions in moderate to severe pain compared with those residing in nursing homes that did not do this type of personalized...

Mia Wadelius is Professor of Clinical Pharmacogenetics at Uppsala University and Senior Physician of Clinical Pharmacology at Akademiska Sjukhuset.

184/6: 15 Assessing the clinical impact of ethnicity - specific pharmacogenetic allele variation in over 100,000 patients with biobank - linked electronic medical records.

He participates in national and international advisory committees on pharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European Medicipharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Working Group of the European Medicine Agency (EMA).

These investigators use a clever pharmacogenetic approach, combining cell - specific expression of the porcine liver esterase (PLE) with delivery of MK801 linked to 4 - hydroxy -3-nitrobenzyl carbamate through a carboxymethylpropyl ester group.

Our pharmacogenetics testing helps on the medication side while working on removal from Medications and the application of lifestyle strategies.

Pharmacogenetics: This branch is related to the clinical testing of genetic variation that primarily gives rise to the differing response to human - made drugs.

Pharmacogenetics is a novel technology, making its way out of academia into the general medical community and is considered «disruptive medicine.»